Finance

Lists
Why is 000100 down 2.54%?
Dive Deeper
000100:KRX
Yuhan Corp
â‚©72,800.00
-2.54%
(-1,900.00) 1D
Sep 29, 12:50:26 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 000100...
Open
â‚©74,400
High
â‚©74,500
Low
â‚©72,700
Mkt. cap
5.44T
Avg. vol.
240.42K
Volume
86.50K
Dividend
0.82%
Quarterly dividend
â‚©150
Ex-dividend date
Feb 26, 2026
P/E ratio
22.88
52-wk high
â‚©129,200
52-wk low
â‚©65,000
EPS
â‚©3,181
Shares outstanding
73.62M
No. of employees
2K
Open
â‚©74,400
High
â‚©74,500
Low
â‚©72,700
Mkt. cap
5.44T
Avg. vol.
240.42K
Volume
86.50K
Dividend
0.82%
Quarterly dividend
â‚©150
Ex-dividend date
Feb 26, 2026
P/E ratio
22.88
52-wk high
â‚©129,200
52-wk low
â‚©65,000
EPS
â‚©3,181
Shares outstanding
73.62M
No. of employees
2K
Profile
Yuhan Corporation is a South Korean pharmaceutical and chemical company headquartered in Daebang-dong, Dongjak-gu, Seoul. It was established in 1926 by New Il-han and has been listed on the Korea Stock Exchange since 1962. Yuhan is one of the top Korean pharmaceutical companies, along with Celltrion, Samsung Biologics, GC Pharma, and Hanmi Pharmaceutical. Wikipedia
About Yuhan Corp
CEOWook Je Cho
Employees2.09K
Founded1926
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
Revenue
Cost of goods sold
Cost of revenue
Research and development expenses
Total research and development expenses
Selling, general, and admin expenses
Operating expense
Total operating expenses
Operating income
Other non operating income
EBT including unusual items
EBT excluding unusual items
Income tax expense
Effective tax rate
Other operating expenses
Net income
Net profit margin
Earnings per share
Interest and investment income
Interest expense
Net interest expenses
Depreciation and amortization charges
EBITDA
Gain or loss from assets sale
AI content may include mistakes. Learn more
Google apps